Overview about the measurable markers of the human cartilage metabolism in different body fluids;Uberblick uber den aktuellen stand der messbaren parameter des knorpelstoffwechsels in verschiedenen korperflussigkeiten

Zeitschrift fur Rheumatologie

Volumn 57, Issue 6, 1998, Pages 375-391

  Ettrich, U ^a   Fengler, H ^b   Dressler F ^c   Schulze, K J ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^c Krankenhaus Freital   (Germany)

Author keywords

Aggrecan; Cartilage markers; Chondroitin sulphate; COMP; Crosslinks; Enzymes; Extracellular cartilage matrix; Hyaluronan; Keratan sulphat; Procollagen

Indexed keywords

BIOCHEMICAL MARKER; CHONDROITIN SULFATE; COLLAGEN; CYSTEINE PROTEINASE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; KERATAN SULFATE; MATRIX METALLOPROTEINASE; PROCOLLAGEN; PROTEOGLYCAN; SERINE PROTEINASE; AGGRECAN; BIOLOGICAL MARKER; CARTILAGE MATRIX PROTEIN; COLLAGENASE; GLYCOPROTEIN; LECTIN; SCLEROPROTEIN;

ARTHRITIS; BONE MATRIX; CARTILAGE; CROSS LINKING; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; REVIEW; RHEUMATIC DISEASE; SYNOVIAL FLUID; ARTHROPATHY; ARTICULAR CARTILAGE; CHONDROPATHY; ENZYMOLOGY; METABOLISM; PHYSIOLOGY;

AGGRECANS; BIOLOGICAL MARKERS; CARTILAGE DISEASES; CARTILAGE, ARTICULAR; CHONDROITIN SULFATES; COLLAGENASES; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; HUMANS; HYALURONIC ACID; JOINT DISEASES; KERATAN SULFATE; LECTINS, C-TYPE; PROCOLLAGEN; PROTEOGLYCANS; SYNOVIAL FLUID;

EID: 0032444654     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003930050130     Document Type: Review

References (139)

1. Alsalameh S, Kalden JR, Strohmaier M et al (1990) Hyaluronsäure im Serum von Patienten mit entzündlichen und degenerativen Gelenkerkrankungen - Ergebnisse einer Studie und Übersichtsreferat. Akt Rheumatol 15:133-140
2. Astbury C, Bird HA, McLaren AM et al (1994) Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. Br J Rheumatol 33:11-15
3. Ayad S, Bott-Handford R, Humphries M-J et al (1994) The extracellular matrix facts book. Academic Press Harcourt Brace&Company Publishers. London San Diego New York Boston Sydney Tokyo Toronto, pp 1-163
4. Bayliss MT, Venn M, Maroudas A et al (1983) Structure or proteoglycans from different layers of human articular cartilage. Biochem J 209:387-400
5. Belcher C, Yaqub R, Fawthrop F et al (1997) Synovial fluid chondoitin and keratan sulfate epitopes, glycosaminoglycans and hyaluronan in arthritic and normal knees. Ann Rheum Dis 56:299-307
6. Bonasser LJ, Frank EH, Murray JC et al (1995) Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum 38: 173-183
7. Brandt KD (1989) Osteoarthritis. In: Harrison's Principles of Internal Medicine. MC Graw-Hill Inc. New York, Hamburg London Mexico Paris Singapore Sydney Tokyo Toronto (13th Edition): 1692-1698
8. Brandt KD (1992) Die Pathogenese der Arthrose - The Pathogenesis of Osteoarthritis. EULAR Bull 3:84-91
9. Brandt KD, Thonar EJMA (1989) Lack of association between serum keratan sulfate concentrations and cartilage changes of osteoarthritis after transection of the anterior cruciate ligament in the dog. Arthritis Rheum 32:647-651
10. Campion GV, McCrae F, Schnitzer TJ et al (1991) Levels of keratan sulfate in the serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis Rheum 34:1254-1259
11. Carroll GJ, McCappin S, Bell MC et al Comparison of keratan sulfate concentrations and the size distribution of proteoglycans in the synovial fluid of patients with osteoarthritis and pyrophosphat arthropathy. Rheumatol Int 11:63-68
12. Chevalier X, Groult N, Larget-Piet B et al (1994) Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 37:1013-1022
13. Cs-Szabo G, Roughley PJ, Plaas AHK et al (1995) Large and small proteoglycans of osteoarthritic and rheumatoid articular cartilage. Arthritis Rheum 38:660-668
14. Dahlberg LRH, Ross H, Saxne T et al (1994) Cartilage metabolism in the injured and the uninjured knee of the same patient. Ann Rheum Dis 53:823-827
15. Dreßler F, Laube W (1994) Möglichkeiten zur Diagnostik degenerativer Veränderungen des Knorpel- und Gelenkstoffwechsels mittels biochemischer Parameter im Blut und Urin. Ein kurzer Überblick. Dtsch Z Sportmed 45:39-40
16. Dreßler F, Michalik H (1989) Verfahren zur Isolierung von Glycosaminoglycanen des Blutserums und der photometrischen Bausteinanalyse. Z Med Lab Diagn 30:313-321
17. Dreßler F, Morgenstern K, Böhm R et al (1994) Die Bedeutung von Sulfat für die Proteoglycane bzw. Glycosaminoglycane des Gelenkknorpels - Serumsulfat von Sportlern. In: Regulations- und Repair-mechanismen (33. Deutscher Sportärzte Kongreß. Paderborn 1993). Deutscher Ärzteverlag, pp 456-459
18. Emlen W, Niebur J, Flanders G et al (1976) Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: Correlation with disease activity. J Rheumatol 23:974-978
19. Engström-Laurent A (1989) Changes in hyaluronan concentration in tissue and body fluids in disease states. In: The biology of hyaluronan. Wiley, Chichester (Ciba Foundation Symposium 143): 233-247
20. Engström-Laurent A, Hällgren R (1987) Circulating hyaluronic acid levels vary with physical activity in healthy subjects and rheumatoid arthritis patients: relationship to synovitis mass and morning stiffness. Arthritis Rheum 30:1333-1338
21. Engström-Laurent A, Laurent UBG, Lilja K et al (1985) Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 45:497-504
22. Engström-Laurent A, Lööf L, Nyberg A et al (1985) Increased serum levels of hyaluronate in liver disease. Hepatology 5:638-642
23. Ettrich U (1997) Untersuchungen zur diagnostischen Wertigkeit biochemischer Parameter des Knorpel- und Gelenkstoffwechsels, speziell der Glycosaminoglycane im Blut und Urin bei entzündlichen, degenerativen und traumatischen Kniegelenkserkrankungen unter Einbeziehung einer Gelenkbelastung. Dissertationsschrift Dresden
24. Exer B (1982) Proteoglycane. In: Wissenschaftliche Tabellen Geigy - Somatometrie und Biochemie. Ciba Geigy AG Basel, 8. Auflage, pp 208-213
25. Eyre DR (1991) The collagens of articular cartilage. Semin Arthritis Rheum 21 (Suppl 2):2-11
26. Ferlazzo AM, Vinci R, Panzera M (1991) Glycosaminoglycan concentrations in horse plasma and serum. Differences with other animal species and identification of affecting factors. Comp Biochem Physiol 100B:745-751
27. Fife RS (1992) Imaging, arthroscopy and markers in osteoarthritis. Curr Opin Rheumatol (4):560-565
28. Fife RS, Brandt KD, Braunstein EM et al (1991) The presence of cartilage matrix glycoprotein in serum as determined by immunolocation analysis is not a sensitive indicator of early osteoarthritis of the knee. J Lab Clin Med 117:332-338
29. Forslind K, Eberhardt K, Jonsson et al (1992) Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. Br J Rheumatol 31:593-598
30. Glückert K (1995) Praxisrelevante Grundlagen-Arthrose. In: Praktische Orthopädie-Arthrose. Hrsg: Holfelder G. Georg Thieme Verlag, Stuttgart New York (Bd. 25):19-33
31. Goldberg RL, Huff JP, Lenz ME et al (1991 ) Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 34:799-807
32. Gough AKS, Peel NFA, Eastell R et al (1994) Excretion of pyridinium cross-links correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis 53:14-17
33. Greenwald RA (1996) Monitoring collagen degradation in patients with arthritis. Arthritis Rheum 39:1455-1465
34. Gressner AM, Neu HH (1984) N-terminal procollagen peptide and β2-microglobulin in synovial fluids from inflammatory and non-inflammatory joint diseases. Clin Chim Acta 141:241-245
35. Halliwell B (1995) Oxygen radicals, nitric oxide and human inflammatory joint disease. Second International Meeting on Synovium 21-23 September 1994, Canterbury. Ann Rheum Dis 54:505-510
36. Haraoui B, Thonar EJMA, Martel-Pelletier J et al (1994) Serum keratan sulfate levels in rheumatoid arthritis. Inverse correlation with radiographic staging. J Rheumatol 21:813-817
37. Hardingham T, Bayliss M (1990) Proteoglycans of articular cartilage. Changes in aging and in joint diseases. Semin Arthritis Rheum 20 (Suppl 1): 12-33
38. Hardingham TE, Fosang AJ (1995) The structure of aggrecan and its turnover in cartilage. J Rheumatol 22 (Suppl 43):86-90
39. Hardingham TE, Fosang AJ, Dudhia J (1994) The structure, function and turnover of aggrecan, the large aggregating proteoglycan from cartilage. Eur J Clin Chem Clin Biochem 32:249-257
40. Hascall VC, Giant TT (1987) Proteoglycan epitopes as potential markers of normal and pathologic cartilage metabolism. Arthritis Rheum 30:586-588
41. Hazell PK, Dent C, Fairclough JA et al. (1995) Changes in glycosaminoglycan epitope levels in knee joint fluid following injury. Arthritis Rheum 38:953-959
42. Hedbom E, Antonsson P, Hjerpe A et al (1992) Cartilage matric proteins. J Biol Chem 267:6132-6136
43. Hedin PJ, Weitoft T, Hedin H et al (1991) Serum concentrations of hyaluronan and proteoglycan in joint disease. Lack of association. J Rheumarol 18: 1601-1605
44. Hein G, Müller A, Franke S et al (1995) Untersuchungen zur Korrelation der Pyridinium-Crosslinks (gemessen im Urin und im Serum) bei der rheumatoiden Arthritis. Akt Rheumatol 20:140-144
45. Heinegard D, Oldberg A (1989) Structure and biology of cartilage and bone matrix noncollagenous macromolecules. FASEB J 3:2042-2051
46. Heinegard D, Saxne T (1991) Macromolecular markers in joint diseases. J Rheumatol 18 (Suppl 27):27-29
47. Heinegard D, Saxne T (1991) Molecular markers of processes in cartilage in joint disease. Br J Rheumatol 30 (Suppl 1): 21-24
48. Hellio de Graverand MP, Tron AM, Ichou M et al (1996) Assessment of urinary hydroxypyridinium cross-links measurement in osteoarthritis. Br J Rheumatol 35:1091-1095
49. Henrotin Y, Deby-Dupont G, Deby C et al (1992) Active oxygen species, articular inflammation and cartilage damage. In: Free Radicals and Ageing. Birkhäuser Verlag. Basel, pp 308-322
50. Horslev-Petersen K (1990) Circulating extracellular matrix components as markers for connective tissue response to inflammation. Dan Med Bull 37:308-329
51. Horslev-Petersen K, Bentsen KD, Engström-Laurent A et al (1988) Serum aminoterminal-type III-procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months treatment with levamisole, penicillamine or azathioprine. Ann Rheum Dis 47:116-126
52. Horslev-Petersen K, Bentsen KD, Junker P et al (1988) Serum aminoterminal-type III-procollagen peptide in inflammatory and degenerative rheumatic disorders. Clin Rheumatol 7:61-68
53. Imanari T, Shinbo A, Ochiai H et al (1992) Study on proteoglycans having low-sulphated chondroitin-4-sulphate in human urine and serum. J Pharmacobio Dyn 15:231-237
54. Kaplan D, Meyer K (1962) The fate of injected mucopolysaccharides. J Clin Invest 41:743-749
55. Kleesiek K, Reinhards R, Greiling H (1988) Zur Pathobiochemie chronischentzündlicher Gelenkerkrankungen. Katabole und anabole Mechanismen im Proteoglykan- und Glycosaminoglycan-Stoffwechsel. Z Med Lab Diagn 29:67-83
56. Konttinen YT, Saari H, Honkanen VEA et al (1990) Serum baseline hyaluronate and disease activity in rheumatoid arthritis. Clin Chim Acta, pp 39-48
57. Kuettner KE (1992) Biochemistry of articular cartilage in health and disease. Clin Biochem 25:155-163
58. Kuettner KE (1994) Osteoarthritis - Cartilage integrity and homeostasis. In: Rheumatology (First Edition). Mosby-Year Book Europe Limited Colchester, Hong-Kong. Osteoarthritis 6.1-6.16
59. Lark MW, MacNaul KA, Donatelli S et al (1994) Induction of increased levels of proteoglycan fragments in synovial fluid and increased levels of stromelysin in cartilage, synovium and SF by intraarticular injection of canine monocyte conditioned medium into dogs. J Rheumatol 21:1716-1724
60. Larking PW, McDonald BW, Taylor ML et al (1987) Urine glycosaminoglycans in a reference population. Effects of age, body surface area and postmenopausal status. Biochem Med Metabol Biol 37:246-254
61. Laurent TC, Fraser JRE (1992) Hyaluronan. FASEB J 6:2397-2404
62. Laurent TC, Fraser JRE, Pertoft H et al (1986) Binding of hyaluronate and chondroitin sulphate to endothelial liver. Biochem J 234:653-658
63. Laurent UBC, Fraser JRE, Engström-Laurent A et al (1992) Catabolism of hyaluronan in the knee joint of the rabbit. Matrix 12:130-136
64. Laurent TC, Lilja K, Brunnenberg L et al (1987) Urinary excretion of hyaluronan in man. Scand J Clin Lab Invest 47:793-799
65. Lindqvist U, Groth T, Lööf L et al (1992) A hyaluron-loading test applied to patients with liver and joint diseases. Clin Chim Acta 210:119-132
66. Lohmander LS (1988) Proteoglycans of joint cartilage-structure, function, turnover and role as markers of joint disease. Baillieres Clin Rheumatol 2:37-62
67. Lohmander LS (1991) Rolle und Bedeutung von Bindegewebsmarkern in Synovia und Serum in der Therapiekontrolle. In: Therapeutische Zugänge zu Gelenkerkrankungen. Hrsg: Raspe HH. Zuckschwerdt Verlag, München Bern Wien San Francisco, pp 28-36
68. Lohmander LS (1994) Molecular markers to monitor outcome and intervention in osteoarthritis. Br J Rheumatol 34:599-601
69. Lohmander LS (1995) Molecular markers of cartilage matrix metabolism - an outcome measure in osteoarthritis. Rheumatology in Europe 24 (Suppl 2):131-133
70. Lohmander LS, Felson DT (1996) Defining the role of molecular markers to monitor disease, intervention and cartilage breakdown in osteoarthritis. OMERACT III Conference, Cairns, Australia. J Rheumatol 24:782-785
71. Lohmander LS, Horner LA, Dahlberg L et al (1993) Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee after injury. J Rheumatol 20:1362-1368
72. Lohmander LS, Lark MW, Dahlberg L et al (1992) Cartilage matrix metabolism in osteoarthritis. Markers in synovial fluid, serum and urine. Clin Biochem 25:167-174
73. Lohmander LS, Neame PJ, Sandy JD et al (1993) The structure of aggrecan fragments in human synovial fluid. Arthritis Rheum 36:1214-1222
74. Lohmander LS, Saxne T, Heinegard DK et al (1994) Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis 53:8-13
75. Lohmander LS, Saxne T, Heinegard DK et al (1996) Increased concentrations of bone sialoprotein in joint fluid after knee injury. Ann Rheum Dis 55:622-626
76. Lohmander LS, Lark MW, Sandy JD et al (1995) Consequences and mechanisms of aggrecan degradation in arthritic cartilage. Rheumatology in Europe 24 (Suppl 2):62-65
77. Lohmander LS, Yoshihara Y, Roos H et al (1996) Procollagen-II-C-Propeptide in joint fluid. Changes in concentration with age, time after knee injury and osteoarthritis. J Rheumatol 23:1765-1769
78. Mac-Donald AG, McHenry P, Robins SP et al (1994) Relationship of urinary pyridinium crosslinks to disease extent and activity in osteoarthritis. Br J Rheumatol 33:16-19
79. Malemud CJ (1993) Markers of osteoarthritis and cartilage research in animal models. Curr Opin Rheumatol 5:494-502
80. Manicourt DH, Fujimoto N, Obata KI et al (1994) Serum levels of collagenase, stromelysin-1 and TIMP-1. Arthritis Rheum 37:1774-1783
81. Manicourt DH, Triki R, Fukuda K et al (1993) Levels of circulating tumor necrosis factor-α and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratan sulfate. Arthritis Rheum 36:490-499
82. Martel-Pelletier J, Pelletier JP (1996) Wanted - The collagenase responsible for the destruction of the collagen network in human cartilage. Br J Rheumatol 35:818-820
83. McLaren AM, Isdale AH, Whitings PH et al (1993) Physiological variations in the urinary excretion of pyridinium crosslinks of collagen. Br J Rheumatol 32:307-312
84. Mehraban F, Finegan CK, Moskowitz RW (1991) Serum keratan sulfate. Arthritis Rheum 34:383-392
85. Mohamed-Ali H (1991) Proteolytische Enzyme und die Destruktion des Gelenkknorpels bei Arthrose und der chronischen Polyarthritis. Wien Med Wochenschr 141:78-86
86. Myers SL, O'Connor BL, Brandt KD (1996) Accelerated clearance of albumine from the osteoarthritic knee. Implications for the interpretation of concentrations of cartilage markers in synovial fluid. J Rheumatol 23:1744-1748
87. Nakashima Y, Di Ferrante N, Jackson RL et al (1975) The interaction of human plasma glycosaminoglycans with plasma lipoproteins. J Biol Chem 250:5386-5392
88. Pavelka K, Seibel MJ (1989) Quantitativer Nachweis Keratansulphat-spezifischer Epitope im Synovialpunktat bei entzündlichen und degenerativen Gelenkerkrankungen. Z Rheumatol 48: 294-300
89. Petersson IF, Sandqvist L, Saxne T et al (1997) Cartilage markers in synovial fluid in symptomatic knee osteoarthritis. Ann Rheum Dis 56:64-67
90. Pitsillides AA, Worrall JG, Wilkinson LS et al (1994) Hyaluronan concentration in non-inflamed and rheumatoid synovium. Br J Rheumatol 33:5-10
91. Poole AR (1993) Cartilage in health and disease. In: Arthritis and Allied Conditions - A Textbook of Rheumatology. Lea&Febinger, Philadelphia London, 12. Aufl. pp 279-333
92. Poole AR (1993) Degradation and remodelling of articular cartilage in osteoarthritis. 19th Symposium of the European Society Osteoarthritis. Noordwijkerhout-Nederland 24-27 May 1992. Eular Publishers, Basel, Congress Reports 1:3-6
93. Poole AR (1994) Immunochemical markers of joint inflammation, skeletal damage and repair. Where are we now? Ann Rheum Dis 53:3-5
94. Poole AR, Witter J, Roberts N et al (1990) Inflammation and cartilage metabolism in rheumatoid arthritis. Arthritis Rheum 33:790-799
95. Poulson JH (1986) Urine and tissue glycosaminoglycans and their interrelations. Dan Med Bull 33:75-96
96. Ramadori G, Zöhrens G, Manns M et al (1991) Serum hyaluronate and type-III-procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J of Clin Invest 21:323-330
97. Ratcliffe A, Shurety W, Caterson B (1993) The quantification of a native chondroitin sulfate epitope in synovial fluid lavages and articular cartilage from canine experimental osteoarthritis and disuse arthropy. Arthritis Rheum 36: 543-551
98. Respondek M, Seibel MS, Lautenschläger J et al (1989) Hyaluronsäure und N-terminales Prokollagen-III-Peptid im Urin bei entzündlichen und degenerativen Gelenkerkrankungen. Z Rheumatol 48:117-122
99. Ricard-Blum S, Chevalier X, Grimaud JA et al (1995) Detectable levels of pyridinoline are present in synovial fluid from various patients with knee effusion: preliminary results. Eur J Clin Invest 25:438-441
100. Riel KA, Jochum M, Bernatt P et al (1991) Differential pattern of PMN-elastase and type-III-procollagen peptide in knee joint effusions due to acute and chronic sports injuries. Klin Wochenschrift 69:830-835
101. Roos H, Dahlberg L, Lindqvist U et al (1995) Markers of cartilage matrix metabolism in human joint fluid and serum: the effect of exercise. Osteoarthritis Cartilage 3:7-14
102. Rorvik AM, Grondahl AM (1995) Marker of osteoarthritis. A review of the literatur. Vet Surg 24:255-262
103. Saari H, Konttinen YT, Nordström D (1991) Effect of joint mobilisation on serum hyaluronate. Ann Med 23:29-32
104. Sames K (1994) The role of proteoglycans and glycosaminoglycans in aging interdisziplinary topics in gerontology vol 28. Karger, Basel, pp 1-140
105. Saxne T, Carlsson A (1990) Cartilage markers in synovial fluid and blood in osteoarthritis and rheumatoid arthritis. Scand J Rheum 19:171-175
106. Saxne T, Heinegard D (1992) Cartilage oligometric matrix protein. A novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 31:583-591
107. Saxne T, Heinegard D (1995) Matrix proteins. Potential as body fluid markers of changes in the metabolism of cartilage and bone in arthritis. J Rheumatol 22 (Suppl 43):71-74
108. Seibel MJ (1989) Komponenten der extrazellulären Gewebematrix als potentialle "Marker" des Bindegewebs-, Knorpel- und Knochenmetabolismus bei Erkrankungen des Bewegungsapparates. Z Rheumatol 48:6-18
109. Seibel MJ, Robins SP, Bilezikian JP (1992) Urinary pyridinium crosslinks of collagen. TEM 3:263-270
110. Seibel MJ, Raimann S, Seglias J et al (1988) Serum-Hyaluronsäure aminoterminales Prokollagen-III-Propeptid bei entzündlichen und degenerativen Gelenkerkrankungen. Z Rheumatol 47:98-106
111. Seibel MJ, Jelsma R, Saed-Nejad F et al (1990) Variability in the immunochemical quantification of keratan sulphate in human and bovine cartilage proteoglycans. Biochem Soc Trans 18:969-970
112. Sharif M, George E, Dieppe PA (1996) Synovial fluid and serum concentrations of aminoterminal propeptide of type-III-procollagen in healthy volunteers and patient with joint disease. Ann Rheum Dis 55:47-51
113. Sharif M, George E, Shepstone L et al (1995) Serum hyaluronic aciod levels as predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 38:760-767
114. Sharif M, Osborne DJ, Meadow K et al (1996) The relevance of chondroitin and keratan sulphate markers in normal and arthritic synovial fluid. Br J Rheumatol 35:951-957
115. Sharif M, Saxne T, Shepstone L et al (1995) Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol 34: 306-310
116. Shinmei M, Inamori Y, Yoshihara X et al (1992) The potential of cartilage markers in joint fluid for drug evaluation. In: Articular Cartilage and Osteoarthritis Editor. Kuettner K et al. Raven Press Ltd., New York, pp 592-609
117. Shinmei M, Kobayashi T, Yoshihara Y et al (1995) Significance of the levels of carboxy terminal type-II-procollagen peptide, chondroitin sulphate isomers, tissue inhibitor of metalloprotein and metalloproteinases in osteoarthritis joint fluid. J Rheumatol 22 (Suppl 43):78-81
118. Simkin PA, Basset JE (1995) Cartilage matrix molecules in serum and synovial fluid. Curr Opin Rheumatol 7:346-351
119. Sinigaglia L, Varenna M, Binelli L et al (1995) Urinary and synovial pyridinium crosslink concentrations in patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 54:144-147
120. Slater RR, Bayliss MT, Lachiewicz PF et al (1995) Monoclonal antibodies that detect biochemical markers of arthritis in humans. Arthritis Rheum 38:655-659
121. Spector TD, Woodward L, Hall GM et al (1992) Keratan sulphate in rheumatoid arthritis, osteoarthritis and inflammatory diseases. Ann Rheum Dis 51:1134-1137
122. Staprans I, Felts JM (1985) Isolation and characterisation of glycosaminoglycans in human plasma. J Clin Invest 76:1984-1991
123. Sweet MBE, Coelho A, Schnitzler CM (1988) Serum keratan sulfate levels in osteoarthritis patients. Arthritis Rheum 31:648-652
124. Sweet MBE, Jamkin I, Coelho A et al. (1992) Serum keratan sulfate levels in marathon runners. Int J Sports Med 13:348-350
125. Takahashi M, Kushida K, Hoshino H (1996) Concentrations of pyridinoline and deoxypyridinoline in joint tissue from patients with osteoarthritis or rheumatoid arthritis. Ann Rheum Dis 55:324-327
126. Thompson PW, Spector TD, James IT et al. (1992) Urinary collagen crosslinks reflect the radiographic severity of knee osteoarthritis. Br J Rheumatol 31:759-761
127. Thonar EJMA, Masuda K, Lenz ME (1995) Serum markers of systemic disease processes in osteoarthritis. J Rheumatol 22 (Suppl 43):68-70
128. Thonar EJMA, Häuslemann HJ, Lenz ME et al (1994) Biological markers in osteoarthritis. Z Rheumatol 53:193-194
129. Thonar EJMA, Lenz ME, Klintworth GK et al (1985) Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum 28:1367-1376
130. Thonar EJMA, Manicourt DM, Williams J et al (1991) Circulating keratan sulfate. A marker of cartilage proteoglycan catabolism in osteoarthritis. J Rheumatol 19 (Suppl 27):24-26
131. Tyler JA, Bolis S, Dingle JT (1992) Mediators of matrix metabolism. In: Articular Cartilage and Osteoarthritis. Workshop Conference, Hoechst Wiesbaden, May 1991. Raven Press, New York, pp 251-264
132. Uebelhart D, Gineyts E, Chapuy MC et al (1990) Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 8:87-96
133. Waters PJ, Lewry EM, Brimble AP et al (1992) Factors affecting the assay of urinary free and bound sialic acid. Biochem Soc Trans 20:366
134. Westacott CI, Sharif M (1996) Cytokines in osteoarthritis. Mediators or markers of joint destruction? Semin Arthritis Rheum 25:254-272
135. Wollheim FA (1994) New insight into joint damage from analysis of released biochemical markers. Br J Rheumatol 33:1-4
136. Wollheim FA (1995) Biochemical markers of tissue destruction in rheumatoid arthritis. Rheumatology in Europe 24 (Suppl 2): 173-175
137. Worral JG, Bayliss MT, Edwards JCW (1991) Morphological localisation of hyaluronan in normal and diseased synovium. J Rheumatol 18:1466-1472
138. Woessner JF (1991) Serum hyaluronen. A status report from the joint. Arthritis Rheum 34:927-930
139. Yanagishita M (1993) Function of proteoglycans in the extracellular matrix. Acta Pathol Jpn 43:283-293